Unknown

Dataset Information

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.


ABSTRACT:

Background

Coronaviruses pose a serious threat to global health as evidenced by Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and COVID-19. SARS Coronavirus (SARS-CoV), MERS Coronavirus (MERS-CoV), and the novel coronavirus, previously dubbed 2019-nCoV, and now officially named SARS-CoV-2, are the causative agents of the SARS, MERS, and COVID-19 disease outbreaks, respectively. Safe vaccines that rapidly induce potent and long-lasting virus-specific immune responses against these infectious agents are urgently needed. The coronavirus spike (S) protein, a characteristic structural component of the viral envelope, is considered a key target for vaccines for the prevention of coronavirus infection.

Methods

We first generated codon optimized

SUBMITTER: Kim E 

PROVIDER: S-EPMC7128973 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature